Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of active pharmaceutical ingredient (API) and pharmaceutical intermediates. It focuses on penicillin and its API and intermediates, and carbapenem and its API and intermediates. The company was founded on March 20, 2002 and is headquartered in Jingdezhen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company